Web Results

Andrulis v. Celgene: District Court Dismisses Undivided Direct ...

patentlaw.jmbm.com/2014/04/andrulis-v-celgene-district-co.html

Apr 21, 2014 ... Plaintiff Andrulis Pharmaceuticals Corp. ("Andrulis") filed a patent infringement action against Celgene Corporation ("Celgene") alleging direct, ...

Andrulis Pharmaceuticals Corp. v. Celgene Corp., No. 1 ... - Justia Law

law.justia.com/cases/federal/district-courts/delaware/dedce/1:2013cv01644/53249/149/

Jun 26, 2015 ... Andrulis Pharmaceuticals Corp. v. Celgene Corp., No. 1:2013cv01644 - Document 149 (D. Del. 2015) case opinion from the District of ...

Judge Andrews dismisses direct infringement claims in part, finds ...

www.delawareiplaw.com/2014/04/judge_andrews_dismisses_direct.html

Apr 17, 2014 ... In Andrulis Pharmaceuticals Corp. v. Celgene Corporation, C.A. No. 13-1644- RGA (D. Del. Apr. 10, 2014), Judge Richard G. Andrews ...

View Complaint - RPX Search

search.rpxcorp.com/litigation_documents/10301225

Oct 2, 2013 ... For its Complaint, Andrulis Pharmaceuticals Corp., by and through its attorneys, ... (“Celgene”) is a Delaware corporation with its principal.

An Update On Appellate Review Of Indefiniteness - Covington ...

www.cov.com/-/media/files/corporate/publications/2016/05/an_update_on_appellate_review_of_indefiniteness.pdf

May 12, 2016 ... ... and/or some combination of the two.”[10]. Andrulis Pharmaceuticals Corp. v. Celgene Corp. is another example of this type of indefiniteness.

Federal Circuit Decisions - Federal Circuit Court Decisions | Finnegan

www.finnegan.com/publications/federalcircuit/

Netac Technology Co., Ltd. v. Sandisk Corporation ... 07/14/2016. Andrulis Pharmaceuticals Corporation v. Celgene Corporation [rule 36 judgment]. 15- 1962.

Posts in Motion to Strike/Preclude: Delaware Patent Litigation Report

www.morrisjames.com/blogs-Delaware-Patent-Litigation-Report,category,motion-to-strikepreclude

Apr 13, 2016 ... St. Clair Intellectual Property Consultants, Inc. v. Toshiba .... Celgene Corporation , et al. v. Fresenius Kabi .... Andrulis Pharmaceuticals Corp. v.

Patent Docs: Court Report - Patentdocs.org

www.patentdocs.org/2013/10/court.html

Oct 6, 2013 ... Andrulis Pharmaceuticals Corp. v. Celgene Corp. 1:13-cv-01644; filed October 2, 2013 in the District Court of Delaware. Infringement of U.S. ...

Mylan Pharmaceuticals, Inc. v. Celgene Corporation - Federal Trade ...

www.ftc.gov/system/files/documents/amicus_briefs/mylan-pharmaceuticals-inc.v.celgene-corporation/140617celgeneamicusbrief.pdf

Regulatory Framework for Competition in the Pharmaceutical Industry..................... ......... 3 .... 12. Bus. Elecs. Corp. v. Sharp Elecs. Corp.,. 485 U.S. 717 (1988) .

Patent US7230012 - Pharmaceutical compositions and dosage ...

www.google.com/patents/US7230012

Jun 12, 2007 ... Original Assignee, Celgene Corporation ... and conditions such as, but not limited to, leprosy, chronic graft-vs-host disease, rheumatoid arthritis, ...... US5405855, Dec 23, 1993, Apr 11, 1995, Andrulis Pharmaceuticals Corp.

More Info

Celgene Gets Claims Trimmed From Andrulis Drug Patent Suit ...

www.law360.com

Apr 11, 2014 ... The case is Andrulis Pharmaceuticals Corp. v. Celgene Corp., case number 1:13- cv-01644, in the U.S. District Court for the District of Delaware.

District Court Finds Enhanced Patent Indefiniteness - PharmaPatents

www.pharmapatentsblog.com

Aug 4, 2015 ... I don't usually write about district court decisions, but the patent indefiniteness ruling in Andrulis Pharmaceuticals Corp. v. Celgene Corp.

RULE 36 JUDGMENT - US Court of Appeals for the Federal Circuit

www.cafc.uscourts.gov

Jul 14, 2016 ... ANDRULIS PHARMACEUTICALS CORPORATION,. Plaintiff-Appellant v. CELGENE CORPORATION,. Defendant-Appellee ...